1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Gain Important Insights into Clinical Trials at the 13th Annual Clinical Trials in CNS Event

SMi is delighted to announce its 13th annual Clinical Trials in CNS Conference that will be held in London. With an ever increasing average life expectancy, neurodegenerative diseases are becoming more prevalent in society.

Clinical Trials in CNS
Clinical Trials in CNS
PRLog - Jul. 4, 2014 - LONDON, U.K. -- SMi is delighted to announce its 13th annual Clinical Trials in CNS Conference. With an ever increasing average life expectancy, neurodegenerative diseases are becoming more prevalent in society. With this comes the need for new and improved therapies for treating neurodegenerative conditions. From Alzheimer's to Parkinson's disease, the target and mechanism by which a disease manifests itself presents unique challenges in how to approach such treatments not to mention ethical and legal issues behind treatment and trial design.

This conference will give delegates the opportunity to gain additional insights into the best practices in clinical trials, as well as address the challenges in CNS research and by looking at the latest pre-clinical and clinical studies.

This is an opportunity not to be missed, as we delve into the complex and exciting world of Central Nervous System discovery, allowing delegates to learn, explore and debate the key areas of CNS, its preclinical discovery and its clinical trials.

Reasons to Attend:

• Examine the multi-stakeholder approach to self-management and multidisciplinary care in patients with MS

• Discuss the past, present and future of CNS medicines research

• Analyse novel biomarkers for the brain

• Understand the recent failures in CNS development and how translation did not work

• Review the collaboration between industry and academic partnering

Key Speakers:

Tine Bryan Stensbøl, Divisional Director Discovery Pharmacology Research, Lundbeck

Alan Palmer, Co-Founder and Director, MS Therapeutics

Veronique Bragulat, Clinical Imaging Manager, GSK

Sophie Dix, Senior Research Scientist, Neurodegenerative Disease Drug Hunting Team, Eli Lilly

David Willé, Applied Statistician, GSK

Peter Joseph Jongen, Founding Director, MS4 Research Institute

Ernst-Wilhelm Radue, CEO, MIAC AG

Edwin Johnson, Director, Stockholm Brain Institute

Shahid Zaman, Affiliated Lecturer, University of Cambridge

For more information please visit www.smi-online.co.uk/2014clinicaltrialscns53.asp

If you would like to attend this conference as a delegate please contact Filipa Ribeiro on +44 (0) 207 827 6020 or e-mail fribeiro@smi-online.co.uk

If you are interested in sponsoring this event contact Alia Malick on +44(0)20 7827 6168 or email amalick@smi-online.co.uk

If you would like to become a media partner contact Sarah Watson on +44 (0)20 7827 6134 or email swatson@smi-online.co.uk

Sarah Watson
0207 827 6134


--- End ---

Click to Share

Contact Email:
***@smi-online.co.uk Email Verified
Source:SMi Group Ltd
Location:London - London - United Kingdom
Industry:Event, Health
Tags:clinical trials, cns, pharma, central nervous system, trial design
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
Click to Share